Princeton drug research symposia

Announcements TRANSFORMING GROWTH FACTOR+s: THERAPEUTICS

CHEMISTRY, BIOLOGY, AND

The New York Academy of Sciences will sponsor this conference on May 18-20, 1989, at the Key Bridge Marriott, Arlington, Virginia. The TGF-Ps are receiving major attention as regulators of growth and differentiation. They appear to function in the immune and hematopoietic systems, bone growth and repair, wound healing, and cancer. This broad spectrum of activity suggests that control of the TGF-Ps is a key to understanding biological mechanisms. This conference will consider these aspects as well as the potential for therapeutic application of the TGF-Ps. For further information please contact: Conference Department, The New York Academy of Sciences, 2 East 63rd Street, New York, NY 10021, USA; (212) 838-0230. PRINCETON DRUG RESEARCH SYMPOSIA This series of symposia is organized by Dialog in Science at the Hyatt Regency, Princeton, New Jersey. The first two symposia are: “Current and Future Trends in Anticonvulsant, Anxiety and Stroke Therapy”; May 2123, 1989; convener: Dr Michael Williams,

Ciba-Geigy,

USA

“Microbial Metabolites as Sources of New Drugs”; September 24-26,1989; Dr L. Nisbet, Xenova, UK.

For further information, 12 High

Street,

convener:

contact Dr. John Emmett, Dialog in Science, The Studio,

Wheathampstead,

Herts AL4 8AA,

UK; Telephone:

058 283 4117.

93